All Industries

Top Biotech Companies

7,741 Biotech companies, sorted by total funding raised.

Tizona Therapeutics

Tizona Therapeutics translates novel scientific insights into first-in-class immunotherapies desi...

South San Francisco, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$370.0MJul 2020
Human Longevity

Human Longevity combines genomic science with clinical care to detect disease before symptoms and...

San Diego, United States51–200Biotech
Series BTotal funding$369.8MAug 2024
Vividion TherapeuticsAcquired

Vividion Therapeutics is a Bayer-owned biopharmaceutical company using chemoproteomics-based drug...

San Diego, United States201–500Biotech, Drug Discovery
Series CTotal funding$368.0MFeb 2021
Alentis Therapeutics

Alentis Therapeutics develops anti-Claudin-1 antibodies and antibody-drug conjugates for Claudin-...

Basel, Switzerland51–200Biotech, Drug Discovery
Series DTotal funding$365.9MNov 2024
Beacon Therapeutics

Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...

London, United Kingdom51–200Biotech
Series CTotal funding$365.0MJan 2026
Windward Bio

Clinical-stage drug development company improving outcomes for people with advanced immunological...

Basel, United States1–10Biotech, Healthcare
Growth EquityTotal funding$365.0MMay 2026
DELFI Diagnostics

Develops blood-based liquid biopsy tests using fragmentomics and machine learning to detect and m...

Baltimore, United States51–200Artificial Intelligence, Biotech
Venture RoundTotal funding$364.8MDec 2025
Oricell Therapeutics

Oricell develops next-generation cell therapies addressing unmet needs in oncology and immunology...

Shanghai, China51–200Oncology, Therapeutics
Venture RoundTotal funding$364.0MApr 2026
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025
Ventus Therapeutics

Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...

Montreal, Canada11–50Biotech, Drug Discovery
GrantTotal funding$360.1MApr 2023
Nalu MedClosed

Medical device company making FDA-cleared neurostimulation system for chronic nerve pain.

Carlsbad, United States51–200Biotech, Healthcare
Series FTotal funding$358.0MSep 2024
Terremoto Biosciences

Clinical-stage biotech company using covalent chemistry to develop small molecule medicines for o...

South San Francisco, United States51–200Biotech
Series CTotal funding$358.0MJan 2025
ATAI BeckleyAcquired

Clinical-stage biopharmaceutical company developing mental health treatments, formed from merger ...

New York, United States51–200Biotech, Healthcare
Series DTotal funding$357.1MMar 2021
Inari Agriculture

AgTech company using AI-enabled predictive design and multiplex gene editing to create superior s...

Cambridge, United States201–500Biotech
Series G+Total funding$357.0MJan 2024
BE Biopharma

Biotech company pioneering Engineered B Cell Medicines (BCMs) to treat genetic diseases like Hemo...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$356.0MJan 2025
TyraIPO

Clinical-stage biotech (Nasdaq: TYRA) developing precision medicines targeting acquired resistanc...

Carlsbad, United States51–200Biotech, Healthcare
Series BTotal funding$356.0MMar 2021
PIONYR ImmunotherapeuticsAcquired

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...

South San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$355.0MJun 2020
Inscripta

Inscripta is now part of Manus, combining its work with Manus to accelerate the transition to Bio...

Boulder, United States51–200Biotech
Growth EquityTotal funding$353.5MApr 2021
ExscientiaAcquired

AI-driven drug design and development company using machine learning to create more effective med...

Oxford, United Kingdom201–500Artificial Intelligence, Biotech
Series DTotal funding$351.0MApr 2021
Nature's Fynd

Nature's Fynd makes nutritious fungi-based meat and dairy alternatives using Fy protein, born fro...

San Francisco, United States51–200consumer packaged goods, Biotech
Series CTotal funding$350.0MJul 2021
Nephron Pharmaceuticals

Nephron Pharmaceuticals manufactures sterile respiratory, ophthalmic, and compounded medications ...

West Columbia, United States501–1000Biotech, Healthcare
Venture RoundTotal funding$350.0MAug 2023
PozenClosed

POZEN Inc. is a pharmaceutical company developing therapeutic advancements for diseases with unme...

Chapel Hill, United States11–50Biotech
Corporate RoundTotal funding$350.0M
AffinivaxAcquired

Affinivax developed next-generation pneumococcal vaccine candidates using its MAPS platform befor...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$348.5MJan 2021
Hemab Therapeutics

Hemab develops targeted therapies designed to prevent and treat serious bleeding and thrombotic d...

Cambridge11–50Biotech, Healthcare
Series CTotal funding$347.0MMar 2026
Immatics N.V.IPO

Immatics develops and delivers novel PRAME immunotherapies for cancer patients through precision ...

Tuebingen, Germany201–500Biotech, Healthcare
Corporate RoundTotal funding$346.7MDec 2025